103 employees
Cyagen Biosciences specializes in genetically modified rodent models, cell, and gene therapy solutions for research and development.
2005
$41M
from 2 investors over 2 rounds
Cyagen US Inc. raised $41M on February 26, 2020
Investors: GF Securities and GF Xinde Investment Management Co.,Ltd